azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['vidaza', 'venclexta', 'myeloid', 'leukemia', 'aza ', 'pivekimab', '$imgn', 'immunogen ']
#immunogen presents findings from expansion cohorts in phase 1b/2 study of #pivekimabsunirine with #vidaza and #venclexta in #acutemyeloidleukemia at #ash22 $imgn 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.